Hls Therapeutics Inc (HLS.TO)
3.97 x 2100 4.00 x 400
Post-market by (Cboe BZX)
4.00 +0.04 (+1.01%) 03/14/25 [TSX]
3.97 x 2100 4.00 x 400
Post-market 4.00 unch (unch) 15:59 ET
for Fri, Mar 14th, 2025
Results
download Want to compare other data? Select Fields| Symbol | HLS.TO | CRDL.TO | LOVE.VN | ||
| Company | Hls Therapeutics Inc | Cardiol Therapeutics Inc | Cannara Biotech Inc | ||
| Price Information | |||||
| Exchange | TSX | TSX | TSX Venture | ||
| Open | 4.14 | 1.67 | 1.300 | ||
| High | 4.14 | 1.72 | 1.390 | ||
| Low | 3.95 | 1.61 | 1.300 | ||
| Last | 4.00 | 1.63 | 1.390 | ||
| Change | +0.04 | -0.03 | +0.010 | ||
| % Change | +1.01% | -1.81% | +0.72% | ||
| Volume | 9,900 | 76,500 | 92,229 | ||
| 20-Day Average Volume | 6,861 | 82,223 | 65,041 | ||
| Previous Close | 3.96 | 1.66 | 1.380 | ||
| Industry | TSX Drug Specialty & Generic | TSX Drug Specialty & Generic | TSX Drug Specialty & Generic | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 4.12 | 1.66 | 1.303 | ||
| 20-Day Raw Stochastic | 21.62% | 38.46% | 75.86% | ||
| 20-Day Relative Strength | 46.51% | 44.76% | 65.23% | ||
| Weighted Alpha | +5.37 | -39.62 | +75.74 | ||
| Today's Opinion | 56% Buy | 100% Sell | 100% Buy | ||
| Previous Opinion | 56% Buy | 100% Sell | 100% Buy | ||
| Last Month's Opinion | 100% Buy | 88% Sell | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.99% since 03/07/25 | -2.98% since 03/07/25 | +6.11% since 03/07/25 | ||
| Low | 3.92 on 03/13/25 | 1.50 on 03/12/25 | 1.230 on 03/11/25 | ||
| High | 4.15 on 03/13/25 | 1.72 on 03/14/25 | 1.400 on 03/13/25 | ||
| 1-Month | |||||
| %Chg | -4.76% since 02/14/25 | -5.23% since 02/14/25 | +12.10% since 02/14/25 | ||
| Low | 3.92 on 03/13/25 | 1.48 on 03/04/25 | 1.170 on 03/04/25 | ||
| High | 4.29 on 03/03/25 | 1.87 on 02/21/25 | 1.460 on 02/28/25 | ||
| 3-Month | |||||
| %Chg | +9.89% since 12/13/24 | -13.76% since 12/13/24 | +93.06% since 12/13/24 | ||
| Low | 3.35 on 12/17/24 | 1.48 on 03/04/25 | 0.660 on 12/18/24 | ||
| High | 4.31 on 01/21/25 | 2.12 on 02/07/25 | 1.460 on 02/28/25 | ||
| 6-Month | |||||
| %Chg | +22.70% since 09/13/24 | -51.63% since 09/13/24 | +117.19% since 09/13/24 | ||
| Low | 3.00 on 10/25/24 | 1.48 on 03/04/25 | 0.570 on 10/02/24 | ||
| High | 4.31 on 01/21/25 | 3.40 on 09/16/24 | 1.460 on 02/28/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 125,900 | 135,462 | 125,089 | ||
| Shares Outstanding, K | 31,793 | 81,603 | 90,644 | ||
| Annual Sales | 63,074,000 | 0 | 81,747,551 | ||
| Annual Net Income | -27,531,000 | -28,128,292 | 6,438,484 | ||
| Last Quarter Sales | 14,085,000 | 0 | 25,070,414 | ||
| Last Quarter Net Income | -4,844,000 | -12,728,484 | 2,305,863 | ||
| 60-Month Beta | 0.81 | 0.94 | 0.26 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.15 on 11/07/24 | -0.18 on 11/14/24 | 0.03 on 01/27/25 | ||
| Latest Earnings Date | 05/08/25 | N/A | N/A | ||
| Most Recent Dividend | 0.050 on 04/27/23 | N/A | N/A | ||
| Next Ex-Dividends Date | 04/27/23 | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | N/A | N/A | 17.25 | ||